Signal strength of ADE at the drug level ranked by reports. by Jun Hua Lai (22676523)

Subjects:

Outcomes distribution of drug patients with the top 50 positive signal frequency by 4 methods (ROR PRR IC MGPS). by Jun Hua Lai (22676523)

Subjects:

Time-to-onset analysis using the Weibull distribution test. by Jun Hua Lai (22676523)

Subjects:

Characteristics of AEs reports. by Jun Hua Lai (22676523)

Subjects:

Top 50 drugs sorted by frequency of positive signals stratified by reporter – by 4 methods (ROR PRR IC MGPS). by Jun Hua Lai (22676523)

Subjects:

Gender Difference analysis of the top 50 drugs ranked by frequency by four methods (ROR PRR IC MGPS). by Jun Hua Lai (22676523)

Subjects:

Top 50 Drugs with positive signals by frequency – by four methods (ROR PRR IC MGPS). by Jun Hua Lai (22676523)

Subjects:

Two-by-two contingency table for disproportionality analysis. by Jun Hua Lai (22676523)

Subjects:

The top 50 drugs by frequency of positive signals stratified by sex – by 4 methods (ROR PRR IC MGPS). by Jun Hua Lai (22676523)

Subjects:

Flowchart. by Jun Hua Lai (22676523)

Subjects:

The top 25 drugs sorted by frequency of positive signals stratified by age – by 4 methods (ROR PRR IC MGPS). by Jun Hua Lai (22676523)

Subjects:

The principles of disproportionate measurement and the criteria for signal detection. by Jun Hua Lai (22676523)

Subjects:

Inclusion and exclusion criteria. by Ignacio Bórquez (22477946)

Subjects:

Keywords and queries for search strategy of harm reduction services in LAC for PubMed. by Ignacio Bórquez (22477946)

Subjects:

Flow chart for the study selection. by Ignacio Bórquez (22477946)

Subjects:

Extraction data table for peer-reviewed literature. by Ignacio Bórquez (22477946)

Subjects: